Hannah Meiselman

I support SB 544-FN because it strengthens transparency and accountability in managed care by requiring clearer notice of formulary changes, maintaining coverage during exception reviews, and improving PBM reporting and documentation. These updates protect patients from abrupt disruptions in access and ensure drug coverage decisions are made through a fair, auditable process.